Literature DB >> 12902977

Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2F.

Silvia Montigiani1, Rolf Müller, Roland E Kontermann.   

Abstract

We have isolated several peptides from random peptide phage display libraries that specifically recognize the cell cycle regulatory transcription factor E2F and inhibit DNA binding of E2F/DP heterodimers (E2F-1, E2F-2, E2F-3, E2F-4 or E2F-5, and DP-1). The inhibitory efficiency could be strongly enhanced by generating branched tetravalent molecules. To analyse the biological consequences of peptide-mediated E2F inhibition, we fused two of these branched molecules to a cell-penetrating peptide derived from the HTV-Tat protein. Incubation of human tumor cells with these branched Tat-containing peptides led to an inhibition of cell proliferation and induction of apoptosis. These results provide new insights into the function of E2F and further validate E2F as a potential therapeutic target in proliferative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902977     DOI: 10.1038/sj.onc.1206495

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  E2F1 Expression and Apoptosis Initiation in Crayfish and Rat Peripheral Neurons and Glial Cells after Axonal Injury.

Authors:  Valentina Dzreyan; Moez Eid; Stanislav Rodkin; Maria Pitinova; Svetlana Demyanenko
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

2.  A small-molecule E2F inhibitor blocks growth in a melanoma culture model.

Authors:  Yihong Ma; Courtney A Kurtyka; Sandhya Boyapalle; Shen-Shu Sung; Harshani Lawrence; Wayne Guida; W Douglas Cress
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation.

Authors:  M Sangwan; S R McCurdy; I Livne-Bar; M Ahmad; J L Wrana; D Chen; R Bremner
Journal:  Oncogene       Date:  2012-01-30       Impact factor: 9.867

Review 4.  The broken cycle: E2F dysfunction in cancer.

Authors:  Lindsey N Kent; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

5.  LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.

Authors:  Kairit Tints; Madis Prink; Toomas Neuman; Kaia Palm
Journal:  Int J Mol Sci       Date:  2014-04-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.